Literature DB >> 35940730

Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy.

Jasmohan S Bajaj1, Angela Gentili2, James B Wade3, Michael Godschalk2.   

Abstract

As the world's population ages, diseases predominantly found in the elderly now overlap with diseases that were thought to be the purview of younger patients. This includes chronic liver disease, which affects more than 2 billion people worldwide. Owing to the obesity epidemic (and associated metabolic diseases), nonalcoholic fatty liver disease has become the most common cause of chronic liver disease and cirrhosis. A major complication of cirrhosis is hepatic encephalopathy (HE), which becomes challenging to diagnose in elderly patients. HE is usually included in the differential diagnosis of acute delirium but not of reversible dementias. To illustrate this point, we present 2 cases of older patients that were misdiagnosed as having dementia and Parkinson's disease or a parkinsonian syndrome but had contributions from cirrhosis. Both cognitive impairment and tremor resolved with treatment of HE.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Dementia; EncephalApp; Lewy Body Dementia; Parkinson’s disease; Progressive Supranuclear Palsy; Wernicke’s Encephalopathy

Mesh:

Year:  2022        PMID: 35940730      PMCID: PMC9373233          DOI: 10.1016/j.cgh.2022.04.035

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  36 in total

Review 1.  Parkinson's disease.

Authors:  C D Marsden
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

Review 2.  Contemporary Epidemiology of Cirrhosis.

Authors:  Jad A Baki; Elliot B Tapper
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

3.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

4.  The animal naming test: An easy tool for the assessment of hepatic encephalopathy.

Authors:  Francesca Campagna; Sara Montagnese; Lorenzo Ridola; Marco Senzolo; Sami Schiff; Michele De Rui; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Carlo Merkel; Paolo Angeli; Oliviero Riggio; Piero Amodio
Journal:  Hepatology       Date:  2017-05-27       Impact factor: 17.425

5.  Serial administration of a modified Richmond Agitation and Sedation Scale for delirium screening.

Authors:  Jennifer G Chester; Mary Beth Harrington; James L Rudolph
Journal:  J Hosp Med       Date:  2011-12-15       Impact factor: 2.960

6.  Cognitive, Functional, and Mortality Outcomes of Attenuated Delirium Syndrome in Stroke Survivors.

Authors:  Akin Ojagbemi; Toyin Bello; Mayowa Owolabi; Olusegun Baiyewu
Journal:  J Geriatr Psychiatry Neurol       Date:  2020-08-06       Impact factor: 2.680

7.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

Authors:  Julie A Schneider; Zoe Arvanitakis; Woojeong Bang; David A Bennett
Journal:  Neurology       Date:  2007-06-13       Impact factor: 9.910

8.  A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis.

Authors:  Diana Apetauerova; Peter Hildebrand; Stephanie Scala; Janet W Zani; LeeAnne Lipert; Erin Clark; Tanya Fennell; Fredric D Gordon
Journal:  Hepatol Commun       Date:  2020-11-26

9.  Animal Naming Test Is Associated With Poor Patient-Reported Outcomes and Frailty in People With and Without Cirrhosis: A Prospective Cohort Study.

Authors:  Elliot B Tapper; Brooke Kenney; Samantha Nikirk; Deborah A Levine; Akbar K Waljee
Journal:  Clin Transl Gastroenterol       Date:  2022-01-12       Impact factor: 4.396

10.  Homocysteine and Dementia: An International Consensus Statement.

Authors:  A David Smith; Helga Refsum; Teodoro Bottiglieri; Michael Fenech; Babak Hooshmand; Andrew McCaddon; Joshua W Miller; Irwin H Rosenberg; Rima Obeid
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.